SUNNYVALE, Calif., July 29, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that more than 70 studies on the clinical use of the ...

SUNNYVALE, Calif., May 10, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that clinical studies continue to validate the versatility of the company's CyberKnife® and ...

SUNNYVALE, Calif. and BOSTON, Oct. 28, 2012 /PRNewswire/ -- ASTRO 2012 -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today launched its new TomoTherapy&#xAE ...

Accuray Incorporated (Nasdaq: ARAY) announced today that the company will highlight new CyberKnife ® and TomoTherapy ® technologies at the European Society for Therapeutic Radiology and Oncology ...

Data Highlight Expanding Use of (Ultra) Hypofractionated Treatments, Benefits in Patient Care Made Possible by the Precision and Accuracy of Accuray Technologies "Accuray is committed to advancing ...

Accuray Incorporated (NASDAQ: ARAY) announced today that the first CyberKnife ® M6™ and TomoTherapy ® Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in ...

Keeping in line with its plan to expand through strategic partnerships and joint ventures, Accuray Incorporated ( ARAY) entered into an exclusive three-year group purchasing agreement with a leading ...

Use of the Optimata Virtual Patient (OVP) to predict effects of sunitinib malate in advanced pancreatic cancer. Background: To evaluate the treatment outcome and pattern of failure in the patients ...

Shares of Accuray (ARAY +6.82%) rallied more than 9% on Wednesday after the maker of robot-assisted radiosurgery devices reported a narrower-than-expected fourth-quarter loss. What fueled this big ...

Headquartered in Sunnyvale, CA, Accuray Inc. ARAY recently announced that the Radiotherapy and Medical Oncology Center of Sidi Abdellah, Algeria has finally initiated cancer treatment with the company ...